ICU Medical, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by ICU Medical, Inc. on October 2, 2024, reporting events occurring on September 30, 2024. The Company is a Delaware corporation headquartered in San Clemente, California, with common stock trading on The Nasdaq Stock Market under the symbol ICUI.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and personnel changes rather than financial performance.
Material Changes
The primary material change reported is the appointment of a new senior executive officer. On September 30, 2024, the Board of Directors appointed Mr. Daniel Woolson as President of the Company, effective immediately. Mr. Woolson, 48, previously served as Corporate Vice President and General Manager of Infusion Systems at ICU Medical since 2017. His prior experience includes serving as President of Respiratory Solutions for Becton Dickinson and holding various roles at CareFusion.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on future performance, specific risks, contingencies, or unusual items. The document is limited to the announcement of the executive appointment.
Investor Verification Checklist
- Verify the effective date of Mr. Daniel Woolson's appointment as President.
- Review Mr. Woolson's tenure and specific responsibilities as General Manager of Infusion Systems since 2017.
- Confirm the absence of concurrent financial disclosures in this specific 8-K filing.
- Check subsequent filings for any impact of this leadership change on strategic direction or compensation arrangements.